Publications

Boehnke Tanja, Eggebrecht Lisa, Viet Mareike, Heinemann Klaas, Bauerfeind Anja, How did regional lockdowns during the COVID-19 pandemic affect recruitment into a large multinational cohort study of intrauterine device users? Contraception. 2023; 10.1016/j.contraception.2023.110003.

Barnett Clare, Bauerfeind Anja, von Stockum Sophia, Heinemann Klaas, Thromboembolic safety of norethisterone vs levonorgestrel in combined oral contraceptive users: a pooled analysis of 4 large prospective cohort studies AJOG Global Report. 2022; 10.1016/j.xagr.2021.100041.

Boehnke Tanja, Bauerfeind Anja, Hagemann Christine, Lange Jens A., Heinemann Klaas, Intrauterine device prescribing patterns and types in Europe – a cross-sectional analysis of the European Active Surveillance LCS12 Study. European Gynecology & Obstetrics. 2022; 29–40. 10.53260/EGO.224015 .
Download PDF: Boehnke-et-al.-2022_IUD-prescribing-patterns-and-types-in-Europe_LCS12.pdf

Donders Gilbert, Kopp Kallner Helena , Hauck Brian, Bauerfeind Anja, Frenz Ann-Kathrin, Zvolanek Michal, Stovall Dale W., Bleeding profile satisfaction and pain and ease of placement with levonorgestrel 19.5 mg IUD: findings from the Kyleena® Satisfaction study The European Journal of Contraception & Reproductive Health Care. 2022; 10.1080/13625187.2022.2136939.

Fritzsching Benedikt, Contoli Marco, Porsbjerg Celeste, Buchs Sarah, Rask Larsen Julie, Elliott Lisa, Romano Rogdriguez Mercedes, Freemantle Nick, Long-term real-world effectiveness of allergy immunotherpay in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study The Lancet Regional Health Volume 13. 2022;

Reed Suzanne, Do Minh Thai, Lange Jens A., Koro Carol, Heinemann Klaas, Pregnancy and pregnancy outcomes in a prospective cohort study: Final Results from the Nexplanon Observational Risk Assessment Study (NORA) Contraception. 2022; 10.1016/j.contraception.2022.109920.

O'Kelly James, Bartsch Robert, Kossack Nils, Borchert Julia, Pignot Marc, Hadji Peyman, Real-world effectiveness of osteoporosis treatments in Germany. Arch Osteoporos. 2022; 10.1007/s11657-022-01156-z.

Ding Bo, Pignot Marc, Garal-Pantaler Elena, Villinger Beate, Desta Barnabas, Schmidt Katharina, Golam Sarowar, Stirnadel-Farrant Heide, Schwarting Andreas, Clinical Characteristics, Health Care Resource Utilization, and Costs Associated With Flares in Patients With Systemic Lupus Erythematosus in Germany Ann. Rheum. Dis. - EULAR 2022 Annual European Congress of Rheumatology, June 1–4. 2022;

N Hunnicutt Jake, Schultze Michael, Garal-Pantaler Elena, Pignot Marc, Georgiou Mary Elizabeth, Gairy Kerry, Prevalence of lupus nephritis among patients with systemic lupus erythematosus in Germany Nephrology Dialysis Transplantation, Volume 37, Issue Supplement_3, May. 2022; 10.1093/ndt/gfac071.036.

Schultze Michael, Zema C., Carroll R., Hurst M., Borchert J., Zhong Y., Krause T., Bluhmki T., Partington H., Population estimates of obstructive and non-obstructive hypertrophic cardiomyopathy in the UK and Germany. 2022;

Ding Bo, Pignot Marc, Garal-Pantaler Elena, Villinger Beate, Desta Barnabas, Golam Sarowar, Stirnadel-Farrant Heide, Marinoska Tatjana, Schefzyk Sebastian, Schwarting Andreas, Corticosteroid Use in Patients With Systemic Lupus Erythematosus in Germany: The CHAMOMILE Claims Database Study. DGRh 2022, Berlin, Germany 31 August–3 September. 2022;

Sedaghat-Hamedani F., Zema C., Schultze Michael, Borchert J., Zhong Y., Bluhmki T., Krause T., Schmoelders J., Meder B., Clinical and economic burden of hypertrophic obstructive cardiomyopathy in Germany DGK Herztage 29.09 – 01.10.2022. 2022; 10.1007/s00392-022-02087-y.